Abstract
Physical activity improves quality of life, physical health and mental health, and is also an important protective factor against highly prevalent age-related diseases such as cardiovascular diseases, diabetes, cancer and mental health. With age, physical activity tends to decrease, leading down a vicious cycle that increases vulnerability to disease in the elderly. In the following, we trained neural network architectures to predict age from 115,456 one week-long 100Hz wrist accelerometer recordings from the UK Biobank (R-Squared=63.5±2.4%; root mean squared error=4.7±0.1 years). We achieved this performance by preprocessing the raw data as 2,271 scalar features, 113 time series and four images. We also considered the raw signal at different time scales (weekly activity patterns vs. gait). We then defined accelerated aging for a participant as being predicted older than one’s actual age and aimed to characterize these participants. We performed a genome wide association on the accelerated aging phenotypes to estimate its heritability (h_g2=12.3±0.9%) and identified nine single nucleotide polymorphisms in seven genes associated with it (e.g HIST1H4L, involved in chromatin organization). Similarly, we identified biomarkers (e.g blood pressure), clinical phenotypes (e.g chest pain), diseases (e.g hypertension), environmental (e.g smoking) and socioeconomic (e.g income and education) variables associated with accelerated aging. We conclude that physical activity-derived biological age is a complex phenotype with both genetic and non-genetic factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: NIEHS R00 ES023504; NIEHS R21 ES25052; NIAID R01 AI127250; NSF 163870; MassCATS, Massachusetts Life Science Center; Sanofi. The funders had no role in the study design or drafting of the manuscript(s).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Harvard internal review board (IRB) deemed the research as non-human subjects research (IRB: IRB16-2145).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.